STL Index for: antibiotic

Minocycline is a tetracycline antibiotic, which is often used for acne treatment for its anti-bacterial and anti-inflammatory effects. The mechanism of action, side-effects, and drug interactions are discussed.

Doxycycline is a tetracycline antibiotic, which is used to treat acne and rosacea for its antibacterial and anti-inflammatory effects. Mechanism of action, drug interactions, and side-effects are discussed.

Tetracycline is a broad spectrum antibiotic that is often used to treat acne and roscaea for its antibacterial and anti-inflammatory effects. Mechanism of action, drug interactions, and side-effects are discussed.

Topical treatments remain the mainstay of eczema treatment. This article delves into the topical treatments other than topical corticosteroids: Tar, antibiotics, and anti-itch creams.

Oral treatments for treating eczema: Antibiotics, antihistamines, corticosteroids and cyclosporine A are the focus of this article.

This article discusses the concept of the treatment triangle: Evidence based treatment, treatment based on evidence and clinical experience, and patient preference, and how these concepts intersect.

Eczema creates several complications such as bacterial and viral infections due to exposed skin - from cracking. This article delves into these complications that can arise out of eczema and how to treat them.

A brief discussion of treatment options that are available for various patients. Factors like severity, type of acne, response to previous treatment that are unique to the patient can influence the best course of treatment.

This article is an overview of the common topical agents used for treating acne: Benzoyl peroxide, retinoids, topical antibiotics, azelaic acid, and combination products.

Combination therapy is a strategy of combining antibiotic treatments with other treatments with different mechanisms of action to treat acne. This has the effect of preventing or mitigating the unwanted effects of antibiotic resistant bacteria, and may confer other benefits such as lower required dosage as well.

Oral antibiotics are an important treatment option that is available for treating inflammatory acne. This portal provides an organized list of the most commonly used oral antibiotics for the treatment of acne.

Erythromycin is an antibiotic in the macrolide group and is used in acne treatment. This article provides a summary of erythromycin, including side-effects, uses, and potential drug interactions for both topical and oral indications.

Minocycline is a tetracycline antibiotic which is used for acne treatment. This article provides an overview of minocycline, side-effects, brands, and drug interactions are discussed.

Doxycycline is a tetracycline antibiotic which is used to treat acne for its antibacterial and anti-inflammatory effects. Mechanism of action, side-effects, drug interactions, and various brands were discussed.

Tetracycline was developed in 1953 and is a broad spectrum antibiotic. This article discusses the various indications of tetracycline, side-effects, and drug interactions.

Successful treatment of acne with topical therapy can be achieved with patient education, patient engagement in treatment selection, and counseling on aggravating factors.

Since patient compliance is a concern, a great deal of attention must be given to the methods available to minimize the chance of irritation. In the opinion of the author, this may be the single most important factor influencing the success of topical therapy in acne.

Suitable and unsuitable patient profiles for minocycline is discussed in this article. Important takeaways from clinical experience with minocycline is also in this article.

Dermatological and non-dermatological indications for minocycline ((Minocin®, Dynacin®, Vectrin®) are discussed in depth in this article.

Side effects, safety and risks of Minocycline (Minocin, Dynacin, Vectrin) are discussed in this article. Topics include drug interactions, bacterial resistance, as well as other adverse effects.

Rosacea is a common condition that affects people of all races. More aggressive and innovative uses of existing oral agents have resulted in novel therapeutic approaches, which can provide long-term therapy and sustained remission.

Acne vulgaris remains a therapeutic challenge, in large part due to its multifactorial pathophysiology. Evidence for improved and quicker efficacy with safety and longer remission has been noted with combination therapies.

An in-depth review of Clindoxyl® Gel (Clindamycin Phosphate and Benzoyl Peroxide) including clinical experience, mechanism of action, indications, dosing, efficacy, as well as compliance issues and side-effects.

Bactroban (Mupirocin) Patient Profiles - suitable and unsuitable patients, dosing, compliance and cost issues, as well as cost comparisons with other treatments are detailed in this article.

Accutane was approved for severe, recalcitrant nodular cystic acne unresponsive to other first line therapies. Off label use is also covered.

Novel uses of old medications and new formulations of systemic medications have broadened the therapeutic armamentarium for treating rosacea patients. It is of primary importance to offer patients safe and effective therapies for this chronic and incurable condition, improving both the clinical and psychosocial consequences of rosacea.

Bacterial skin infections are common. This article discusses a range of topics including therapies, the problem of bacterial resistance, folliculitis, and other common infections.

Almost everyone at some point in his or her life will be troubled with mild acne. It can be related to athletic activities, travel, cosmetics, or hormonal changes. Various treatment options are discussed.

Cystic acne is characterized by the formation of cysts enclosing a mixture of keratin and sebum in varying proportions. It is the most severe of the four main types of acne, which are comedonal, papular, pustular, and cystic. Identification and treatment options are discussed.

Recognition and appropriate treatment of these common bacterial skin infections, while at times challenging, can be very rewarding for both the physician and the patient. Selecting the right therapy from the beginning should help minimize complications, reduce the number of hospitalizations, and may also help reduce the climbing incidence of bacterial resistance.

Update on Minocycline HCl SOLODYN™ Extended Release Tablets, Linezolid ZYVOX® 600mg, Tigecycline Tygacil®, and CF-1743.

Management of the patients’ expectations and compliance are crucial aspects of acne treatment. Disease chronicity and long-term treatment should be discussed at length during the initial consultation.

Update on

Educate and counsel. Most patients with acne are teenagers who are very self-conscious about their looks and expect immediate treatment results. However, adult acne is becoming more common, and can be very distressing as well.

Since multiple factors are involved in the pathophysiology of acne, treatment that counteracts the majority of them can be expected to achieve the best results. When considering the options for reducing the P. acnes population, it is best to choose those that do not encourage resistance patterns.

Wound care after laser skin resurfacing is critical for achieving a successful result. The superficial thermal injury created by laser skin resurfacing heals more quickly and with a reduced risk of scarring under occlusion. Effective management techniques can help minimize expected negative effects.

Oral isotretinoin, since its introduction more than 20 years ago, has been and still is the 'gold standard' in the treatment of acne and its variants. This is the only approach to acne with the possibility of a permanent “cure” or long term remission.

There is compelling evidence that oral contraceptives (OCs) are effective in the management of mild-moderate acne vulgaris, as well as cumulative evidence that elevated levels of androgens in acne patients, relative to appropriate controls, are an underlying pathophysiological factor in acne.

Vulvovaginal candidiasis is a common occurrence among women over 25 years of age. The likelihood of developing infection increases with pregnancy, the use of oral contraceptives or antibiotics, or immune disorders. However, in many cases, the etiology of the disorder is unknown.

Allergic contact dermatitis (ACD) is more frequent in the pediatric population and in children with atopic dermatitis (AD) than has hitherto been appreciated. Patch testing, which is mediated by different immune mechanisms than prick skin testing, is both safe and diagnostically useful for individuals with AD.